Titel

Merkliste
1 Ergebnisse

A randomized phase II study of full dose gemcitabine versus..:

Rasmussen, Louise Skau ; Winther, Stine B ; Chen, Inna M...
Rasmussen , L S , Winther , S B , Chen , I M , Weber , B , Ventzel , L , Liposits , G , Johansen , J S , Detlefsen , S , Egendal , I , Shim , S , Christensen , S , Pfeiffer , P & Ladekarl , M 2023 , ' A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01) ' , BMC Cancer , vol. 23 , no. 1 , 552 . https://doi.org/10.1186/s12885-023-11035-6. , 2023

Link: https://pure.au.dk/portal/da/publications/a-randomized..

RT Journal
T1 <Title>A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftuniaarhuspubl:oai:pure.atira.dk:publications_9d477caf-3cd2-405f-b010-d9f8524e6dd9&Exemplar=1&LAN=DE
				
A1 Rasmussen, Louise Skau
A1 Winther, Stine B
A1 Chen, Inna M
A1 Weber, Britta
A1 Ventzel, Lise
A1 Liposits, Gabor
A1 Johansen, Julia Sidenius
A1 Detlefsen, Sönke
A1 Egendal, Ida
A1 Shim, Susy
A1 Christensen, Signe
A1 Pfeiffer, Per
A1 Ladekarl, Morten
YR 2023
K1 Chemotherapy dose
K1 Comorbidity
K1 Frail
K1 Older patients
K1 Pancreatic cancer
K1 Quality of life
K1 Randomized study
K1 Toxicity
JF Rasmussen , L S , Winther , S B , Chen , I M , Weber , B , Ventzel , L , Liposits , G , Johansen , J S , Detlefsen , S , Egendal , I , Shim , S , Christensen , S , Pfeiffer , P & Ladekarl , M 2023 , ' A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01) ' , BMC Cancer , vol. 23 , no. 1 , 552 . https://doi.org/10.1186/s12885-023-11035-6
LK http://dx.doi.org/https://pure.au.dk/portal/da/publications/a-randomized-phase-ii-study-of-full-dose-gemcitabine-versus-reduced-dose-gemcitabine-and-nabpaclitaxel-in-vulnerable-patients-with-nonresectable-pancreatic-cancer-dpcg01(9d477caf-3cd2-405f-b010-d9f8524e6dd9).html
DO https://pure.au.dk/portal/da/publications/a-randomized-phase-ii-study-of-full-dose-gemcitabine-versus-reduced-dose-gemcitabine-and-nabpaclitaxel-in-vulnerable-patients-with-nonresectable-pancreatic-cancer-dpcg01(9d477caf-3cd2-405f-b010-d9f8524e6dd9).html
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)